Latest Strategy News

Viking Mines has uncovered additional tungsten mineralisation in historical stockpiles near the Conquest mine at its Linka Project in Nevada, with ore sorting testwork underway and maiden drilling set for late June.

Energy One Limited reveals solid sales momentum and strategic AI integration under new CEO Ben Tranier, despite slight ARR timing delays and ongoing market complexity.

Nex Metals Explorations and the Wangkatja Tjungula Aboriginal Corporation have formalised a joint venture to combine WTAC’s capital and cultural knowledge with Nex Metals’ technical expertise to pursue gold projects in Western Australia.

Locksley Resources’ maiden diamond drilling at the Desert Antimony Mine reveals high-grade antimony mineralisation extending beneath historic underground workings, including a standout 33.51% Sb intercept.

Kuniko Limited’s Phase 1 drilling at the Commonwealth-Silica Hill Project delivers compelling high-grade gold, silver, and base metal results, validating extensions beyond known mineralisation and setting the stage for a larger Phase 2 program starting in July.

Midas Minerals has reported new high-grade copper and silver intercepts from infill drilling at its T-13 Deposit in Namibia, confirming continuity and expansion potential of the mineralisation. An updated resource estimate is anticipated later this year.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.

Comet Ridge has revised its acquisition deal for Santos’ stake in the Mahalo Gas Project, cutting upfront cash and extending deadlines to navigate new government gas reservation policy uncertainty.

West Wits Mining has locked in a ZAR 875 million senior loan facility with Absa and Nedbank, replacing earlier funding and boosting support for its Qala Shallows project; the first new South African gold mine in over 15 years.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Vection Technologies has secured approximately $1.1 million in new orders for FY26, including a $572k extension with a classified defence partner supported by Dell Technologies and $513k in Algho AI platform contracts across four enterprise sectors.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.